Asco Gi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asco gi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asco Gi Today - Breaking & Trending Today

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm

Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium. ....

United States , Jun Gong , Anthonyb El Khoueiry , Rachnat Shroff , Michael Morse , European Society For Medical Oncology Asia Congress , Onclive Peer Exchange , Systemic Therapy , European Society , Medical Oncology Asia Congress , Second Line Advanced , New England Journal , Asco Gi , Hepatocellular Carcinoma , Ianne Covey , Anwaar Saeed , College Of Medicine University Arizona ,

Considerations for Platinum-based Therapy

Key factors, particularly neuropathy, drive the discussion for platinum-based therapy for patients with non-refractory mCRC. ....

Expert Perspectives , Evolving Treatment , Refractory Metastatic Colorectal Cancer , Asco Gi , Adverse Event Profiles , Hand Foot Skin Reactions , New Data , Real World Study Data , Osero Study , Future Directions , Asco Gi Cancers Symposium ,

Dr Dotan on the Use of Geriatric Assessments to Identify Unique Challenges in GI Cancer

Efrat Dotan, MD, discusses the use of geriatric function assessments in elderly patients with gastroesophageal cancer. ....

Efrat Dotan , Department Of Hematology Oncology , Hematology Oncology Fellowship Training Program , Fox Chase Cancer Center , Medical Oncology , Oncology Fellowship Training Program , Cancers Symposiumshowed , Onclive Tv , Asco Gi ,

Fruzaqla Delays Colorectal Cancer Progression, Prolongs Patient Survival

Findings presented at the 2024 Gastrointestinal Cancers Symposium support Fruzaqla’s potential to provide an improved survival benefit and quality of life for those with previously treated metastatic colorectal cancer. ....

Sebastian Stintzing , Universitaetsmedizin Berlin , Gastric Cancer , Colorectal Cancer , Asco Gi ,

Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC

Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab. ....

Newyork Presbyterian Hospital , New York , United States , Pashtoon Murtaza Kasi , Weill Cornell Medicine , Gastric Cancer , Colorectal Cancer , Asco Gi ,